Basically, is there a possibility for therapy with ovulation inhibitors in hepatitis C with virus persistence and in the acute stage?
Gerken, G.
Der Internist 36(4): 410-411
1995
ISSN/ISBN: 0020-9554 PMID: 7775094 Document Number: 450937
Document emailed within 1 workday
Related Documents
Schley, G.; Hengstebeck, W.; Bock, K.D. 1978: Therapy of acute intermittent porphyria with ovulation inhibitors in women Journal of Clinical Chemistry and Clinical Biochemistry 16(1): 43-44Gregorek, H.; Dzierzanowska-Fangrat, K.; Woynarowski, M.; Jóźwiak, P.; Witkowska-Vogtt, E.; Wojda, U.; Syczewska, M.łg.; Socha, J.; Madalińiski, K. 2005: Persistence of hepatitis B virus in children after interferon-alpha therapy despite the seroconversion in HBsAg/anti-HBs system Przeglad Epidemiologiczny 59(3): 641-649
Gerber, E. 1965: Practical experiences with ovulation inhibitors Influence of ovulation. Medicamentous stimulation and inhibition of ovulation. Report of the 3rd Bavarian-Austrian- Swiss Gynecological Convention, Luzerne, October, 1963 Bibl Gynaecol 32: 135-140
Beletskaia, G.V.; Alekseev, A.N. 1988: Experimental demonstration of the possibility of Batai virus persistence in hibernating female mosquitoes of the genus Anopheles (Diptera: Culicidae) Meditsinskaia Parazitologiia i Parazitarnye Bolezni 4: 23-27
Ohnishi, K.; Nomura, F.; Nakano, M. 1991: Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status American Journal of Gastroenterology 86(8): 1041-1049
Mertens, H.; Böhme, H. 1970: Effect of ovulation inhibitors on acute intermittent porphyria Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(5): 226-228
Reisner, H. 1977: Acute cerebrovascular disorders caused by ovulation inhibitors Psychiatrie Neurologie und Medizinische Psychologie. Beihefte 22-23: 75-80
Sepiashvili, R.I.; Balmasova, I.P.; Kabanova, E.V.; Malova, E.S.; Pleskanovskaia, E.V. 2006: Hepatitis C virus: biology, immunopathogenesis, and NK/NKT cells during viral persistence Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 109-116
Abe, Y.; Uehara, S.; Okamura, K.; Yajima, A.; Saito, T.; Yoshida, Y.; Wagatsuma, S.; Mandai, M. 1993: Possibility of vertical transmission of hepatitis C virus Nihon Sanka Fujinka Gakkai Zasshi 45(3): 263-266
Malyĭ, V.P.; Pen'kov, D.V.; Chiriukina, O.I. 2013: Cycloferon therapy of acute and chronic virus hepatitis C Antibiotiki i Khimioterapiia 58(9-10): 34-40
Kanto, T.; Hayashi, N. 2004: Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl 7(Part 1): 170-174
Naveau, S.; Delfraissy, J.F.; Poitrine, A.; Poynard, T.; Chaput, J.C. 1985: Simultaneous detection of IgM antibodies against the hepatitis a virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis Gastroenterologie Clinique et Biologique 9(2): 109-112
Patorska-Mach, E.; Pieciński, Z.; Siuciak, J. 1972: Incidence of Australia antigen in patients with acute virus hepatitis and chronic hepatic disorders following virus hepatitis in our records Polski Tygodnik Lekarski 27(50): 1975-1977
Wu, C.S.; Chang, K.Y.; Dunn, P.; Lo, T.H. 1995: Acute hepatitis A with coexistent hepatitis C virus infection presenting as a virus-associated hemophagocytic syndrome: a case report American Journal of Gastroenterology 90(6): 1002-1005
Schmidt, U.; Dürr, H.K.; Bode, J.C. 1977: Therapy of acute virus hepatitis with silymarin. Report of a controlled study Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 563-565
Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Favre, D.; Berthillon, P.; Trépo, C. 2002: In vitro hepatitis C. Elimination of lipoproteins associated with cells: an important stage to obtain an efficient infection of human hepatocytes by the hepatitis C virus Revue Medicale de la Suisse Romande 122(4): 205
Pessoa, S.D.; Miyamoto, M.; Ono, E.; Gouvêa, A.íd.F.T.B.; de Moraes-Pinto, M.I.; Succi, R.C.M. 2010: Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART Vaccine 28(6): 1606-1612
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Varshney, J.; Sharma, P.K.; Sharma, A. 2012: A review on an update of NS5B polymerase hepatitis C virus inhibitors European Review for Medical and Pharmacological Sciences 16(5): 667-671